Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Non-Current Assets (2024 - 2025)

Carlsmed (CARL) has disclosed Non-Current Assets for 2 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 39.39% year-over-year to $3.4 million, compared with a TTM value of $16.4 million through Dec 2025, changed N/A, and an annual FY2025 reading of $3.4 million, up 39.39% over the prior year.
  • Non-Current Assets was $3.4 million for Q4 2025 at Carlsmed, up from $3.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $7.1 million in Q2 2025 and bottomed at $2.5 million in Q4 2024.